Documents

Update on the outcomes of Paediatric workshop - D.Karres (EMA)

Update on Patient involvement project and on all ongoing actions identified last year, including RMS, RFI and AxMP - M.Lunzer (CTCG) - M.Al (CTCG)

Update on the Focus Group on Risk-based approaches -E.Stahl (CTCG)

Agenda MSP Advisory Group meeting 18 September 2025

Meeting highlights - MSP Advisory Group 26 Juen 2025

ACT EU workshop report on ICH E6 R3 principles and annex 1

Annexes of report on clinical trials training needs of academia and SMEs

Report on clinical trials training needs of academia and SMEs

Report to monitor the European clinical trials environment (April - June 2025)

Update on patient involvement project_M.Lunzer (CTCG)

Update on upcoming ACT EU workshop on external controls_I.Rondak (EMA)

Update on policy development at the EU level _E.Szepessy (EC)_R.Escobar (EC)

Update on patient involvement project_M.Lunzer (CTCG)

Update on revision of the March 2024 Recommendation paper on the use of Auxiliary Medicinal Products in Clinical Trials - M.Al (CTCG)

Updates from ACT EU and partners

Update from ACT EU Priority Action on Clinical Trials in PHEs_M.Cavaleri (EMA) - M.Al (CTCG) - I.Clamou (EC)

Update from Emergency Task Force_M.Mura (EMA)

Presentation on LICT_flexible safety reporting_T.El-Galaly (EHA)

Presentation on OECD framework_J.Demotes (ECRIN)